We know that most people gain weight back when they get off the drugs, so payers may require some behavioural intervention to accompany drug intake
It is, however, important to acknowledge the other side of the coin: the GLP-1 RAs are associated with rapidly increasing expenditures [15], the use of falsified drugs [16, 17], and adverse events such as gastrointestinal adverse events which may be investigated more in the future along with the increased use of the GLP-1 RAs [18, 19]
L-carnitine is essential to beta-oxidation of quarried fatty acid from mitochondrial membrane by PLA (2)
Your emotional wellbeing matters too
Wegovy (semaglutide) Wegovy is a GLP-1 agonist with the active ingredient semaglutide
Helping Patients Choose the Most Practical Path Forward Cost considerations play an important role in medication selection